Construction of Full-Length Genome Hepatitis B Virus Plasmid with Lamivudine Drug-Resistance Gene

XIANG Feng-mei,LU Jian-xi,WANG Qiang,LI Yong-wei,CHEN Wei,LIU Xu-dong,LI Gang

DOI: https://doi.org/10.3321/j.issn:1000-4718.2009.02.039

2008-01-01

International Journal of Internal Medicine

Abstract:Objective To construct lamivudine drug-resistance recombinant plasmids containing full-length DNA of hepatitis virus B.Methods Full-length HBV-DNA was extracted and amplified by polymerase chain reaction(PCR).Then the PCR product was cloned into pBluescript-SK(-)vector.Primers were designed according to the reverse transcription gene sequence of HBV polymerase and mismatches were introduced into primers.Site-directed mutagenesis of HBV polymerase gene codon was conducted using PCR.Mutants were detached from the PCR product and trsanformed into competent DH5α.Plasmid was extacted from the bacteria and sequenced.Results The agarose gel electrophoresis showed 3.2 kb brand of HBV-DNA amplification,and 6.9 kb brand could be seen after HBV-DNA was ligated with pBluescript-SK(-)vector.Brands of 3.2 kb and 2.9 kb can be seen after the recombiant plasmid was digested with Not I and Sal I,and brand of 6.9 kb can be seen when the mutants were digested with Dpn I.The results of DNA sequencing confirmed that the genotype and serotype of the HBV-DNA in recombiant plasmid is C and adr respectively,and the base sequences of the mutant genes were completely concordant with experiment design.Conclusion Lamivudine drug-resistanse recombinant plasmids were successfully constructed,which can be used in further research.